Quantcast
Last updated on April 17, 2014 at 9:28 EDT

Latest Cytori Therapeutics Stories

2014-03-18 23:21:46

$8.9M Raised in Last Round Enables Heart Institute to Treat Patients with Ischemic Conditions with Their Own Adult Stem Cells Beginning Summer, 2014 in the Bahamas Freeport, Bahamas (PRWEB) March 18, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease (CAD) using adult stem cell therapy, announced today it has raised $8.9 million in its Series B offering. Passion Group founder Ali Shawkat...

2014-03-12 12:29:59

DUBLIN, Mar. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/lkv8bk/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of...

2014-02-21 23:02:24

Okyanos Selects Cytori To Provide Equipment And Supplies To Treat Patients With Coronary Artery Disease Using Their Own Adult Stem Cells Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, and Cytori Therapeutics have announced that they have established a ten year supply agreement for the Celution™ System family of...

2014-02-04 12:28:51

DUBLIN, Feb. 4, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xrndzp/regenerative) has announced the addition of the "Concise Analysis of the International Regenerative Medicine Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new...

2014-02-04 12:27:46

LONDON, Feb. 4, 2014 /PRNewswire/ -- Edison's first report on Cytori Therapeutics, Cardiac Celution, discusses the use of concentrated adipose (fat) derived regenerative cells (ADRC) from the patient, which, when injected into damaged tissues, appear to trigger their healing. Cytori sells Celution, point-of-care disposables and a bedside device to prepare ADRC in 90 minutes or less. The procedure is flexible to use, with a potentially broad range of indications and an affordable price...

2013-12-20 23:01:51

The first patient has been treated as part of The ATHENA Trial, which derives stem cells from the patient’s own adipose (fat) tissue and injects extracted cells into damaged parts of the heart. (PRWEB) December 20, 2013 Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute announced the first patient, a 59 year old Clearwater man, has been treated as part of the ATHENA clinical trial. The trial, sponsored by San Diego-based Cytori Therapeutics, derives stem...

2013-11-22 16:26:10

DUBLIN, November 22, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tntpjc/regenerative) have announced the addition of the "Regenerative Medicine Markets" [http://www.researchandmarkets.com/research/tntpjc/regenerative ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or...

2013-09-19 23:22:52

Reportbuyer.com just published a new market research report: Regenerative Medicines: Bone and Joint Applications. London (PRWEB) September 19, 2013 INTRODUCTION Regenerative medicine in orthopedic applications is a $2.7 billion per year niche sector in America’s $2.6 trillion per year healthcare system. However, it is a sector of immense interest in terms of technical and medical possibilities. The best analogy to the current state of regenerative therapies in the bone and joint healing...

2013-04-09 12:29:52

- Alliance for Regenerative Medicine Announces Final Disease Session Panelists; 16 leading regenerative medicine companies discuss late stage and commercial products - WASHINGTON, April 9, 2013 /PRNewswire/ -- At the first annual Regen Med Investor Day, Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), Cytomedix, Inc. (OTCQX: CMXI) and Mesoblast Limited will be just three of the 16 leading regenerative medicine companies providing updates on recent corporate and clinical...

2013-01-03 08:26:02

WASHINGTON, Jan. 3, 2013 /PRNewswire/ -- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that 18 ARM members will be presenting at the Biotech Showcase 2013 meeting in San Francisco next week. Featuring company presentations by leading organizations in the industry, Biotech Showcase, produced by EBD Group and Demy-Colton Life Science Advisors, has emerged as a high profile forum for...